VSee Health, Inc. VSEED
2.28
0.48
26.67%
as of 25 Sep
- Market cap
- $2.8M
- P/E
- 0.0×
Follow VSEED
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (1,065.78%) | (945.70%) | (541.52%) | 2,466.75% |
+8 more TTM periods Free account |
|
| (56.62%) | (69.53%) | (69.39%) | (46.05%) | ||
ROIC |
(93.65%) | (116.45%) | (602.00%) | 0.00% | |
Return on Tangible Assets |
209.77% | 199.66% | 193.99% | 52.22% | |
Average Days of Receivables |
54.42 | 67.44 | 55.96 | 77.83 | |
Free Cash Flow per Share |
(0.06) | (0.12) | (0.17) | (0.27) | |
Free Cash Flow |
(6.31) | (5.52) | (3.49) | (4.54) | |
Capital Expenditures |
— | (0.06) | (0.05) | (0.04) | |
Piotroski F-Score |
4.00 | 3.00 | 4.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(71.43%) | (64.59%) | (31.05%) | 99.57% | |
Accounts Receivable Turnover |
7.78 | 6.39 | 7.39 | 4.66 | |
Accounts Payable Turnover |
1.08 | 0.86 | 0.78 | 0.52 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
269.01 | 401.06 | 468.95 | 828.44 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.01) | 0.00 | 0.22 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
121.31% | 120.49% | 115.87% | 126.69% | |
Share Based Compensation of Revenue |
6.71% | 8.12% | 7.69% | 9.57% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.41 | 0.23 | 0.45 | |
Depreciation/Fixed assets |
23.09 | 9.94 | 9.00 | 6.48 | |
Capex/Depreciation |
0.00 | (0.02) | (0.02) | (0.02) | |
Revenue per Share |
0.14 | 0.30 | 0.73 | 0.73 | |
Operating CF per Share |
(0.06) | (0.11) | (0.17) | (0.27) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(66.11%) | (92.37%) | (100.65%) | (83.28%) |
Columns are period end dates